⚠️ Disclaimer

CJC-1295 is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.

CJC-1295 (CJC-1295 (Modified GRF 1-29)) is a Growth Hormone Releasing Hormone (GHRH) analog researched for increased growth hormone secretion, improved body composition, better sleep quality, enhanced recovery, anti-aging effects. For beginners, start at the lower end of the dosage range (100-300 mcg) and administer 1-3 times daily, typically before bed via subcutaneous injection.

What Is CJC-1295?

CJC-1295 (CJC-1295 (Modified GRF 1-29)) is a Growth Hormone Releasing Hormone (GHRH) analog. Synthetic peptide analog of GHRH (first 29 amino acids) with four amino acid substitutions for enhanced stability.

It is researched for its potential effects on increased growth hormone secretion, improved body composition, better sleep quality, enhanced recovery, anti-aging effects. The 'no DAC' version is preferred over CJC-1295 DAC because it preserves natural pulsatile GH release rather than creating a sustained elevation that can desensitize receptors and suppress feedback loops.

For beginners: This guide assumes no prior peptide experience. We'll cover everything from what CJC-1295 is to how to reconstitute, inject, and structure your first cycle.

How Does CJC-1295 Work?

CJC-1295 binds to GHRH receptors on anterior pituitary somatotrophs, stimulating growth hormone synthesis and pulsatile secretion through the cAMP-PKA signaling cascade. The 'no DAC' version has a shorter half-life, resulting in more natural GH pulses that mimic the body's endogenous rhythm rather than creating sustained supraphysiological levels.

Understanding the mechanism helps set realistic expectations about what CJC-1295 can and cannot do.

How Do You Get Started With CJC-1295?

Step 1 — Source: Purchase CJC-1295 from a vendor with third-party Certificate of Analysis (COA) testing. This confirms purity (aim for 98%+) and rules out contamination.

Step 2 — Supplies: You'll need bacteriostatic water, insulin syringes (1mL/100-unit), alcohol swabs, and a clean workspace.

Step 3 — Reconstitute: Add BAC water to the CJC-1295 vial — use our peptide calculator for exact amounts. Let the water run down the side of the vial; never spray directly on the powder. Swirl gently.

Step 4 — Dose: Draw 100-300 mcg using the calculator's syringe unit conversion.

Step 5 — Inject: Clean the injection site with alcohol. Pinch a fold of abdominal fat and insert the needle at 45° for subcutaneous injection. Push the plunger slowly and hold for 5 seconds.

Calculate Your CJC-1295 Dose

Use our free peptide dosing calculator to get exact reconstitution math and syringe units for CJC-1295.

Open Calculator →

What Should Your First CJC-1295 Cycle Look Like?

Dosage: Start at the lower end of 100-300 mcg. This lets you assess tolerance before committing to a full cycle.

Frequency: 1-3 times daily, typically before bed via subcutaneous injection.

Duration: 8-12 weeks, often paired with Ipamorelin. Don't cut cycles short — many Growth Hormone Releasing Hormone (GHRH) analog effects take weeks to fully manifest.

Off-cycle: Plan a 4-week break before starting another cycle.

What Side Effects Should Beginners Watch For?

Possible water retention, tingling/numbness in hands (carpal tunnel-like), increased appetite, mild headache, and flushing at injection site. Effects are dose-dependent and typically subside with continued use.

As a beginner, track everything — dose, time, injection site, and any effects (positive or negative). This data helps optimize future cycles.

What Are Common Beginner Mistakes?

Not using BAC water: Sterile water lacks the preservative that prevents bacterial growth. Always use bacteriostatic water.

Inconsistent dosing: Skipping doses or varying timing significantly reduces outcomes. Set a daily alarm.

Poor storage: Reconstituted CJC-1295 must stay refrigerated at 2-8°C. Leaving it at room temperature degrades the compound rapidly.

Buying cheap: Low-cost peptides without COA testing may be underdosed, contaminated, or mislabeled. Quality matters more than price.

Bottom Line for CJC-1295 Beginners

Start at the lower end of 100-300 mcg, dose 1-3 times daily, typically before bed, cycle for 8-12 weeks, often paired with Ipamorelin, and track everything. Source from COA-tested vendors and follow proper reconstitution protocol.

Read our complete peptide beginner's guide for general peptide education beyond CJC-1295.

Complete Guide

CJC-1295 : Benefits, Dosage, Side Effects & Research

Read the Full Guide →

Related Reading

Research-Grade Sourcing

If you're going to research CJC-1295, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.

Ascension → Browse CJC-1295

Particle → Browse CJC-1295

Limitless → Browse CJC-1295

Frequently Asked Questions

What is CJC-1295?

CJC-1295 (CJC-1295 (Modified GRF 1-29)) is a Growth Hormone Releasing Hormone (GHRH) analog. Synthetic peptide analog of GHRH (first 29 amino acids) with four amino acid substitutions for enhanced stability. It is researched for increased growth hormone secretion, improved body composition, better sleep quality, enhanced recovery, anti-aging effects.

What is the recommended CJC-1295 dosage?

Common dosages: 100-300 mcg administered 1-3 times daily, typically before bed via subcutaneous injection. Cycle length: 8-12 weeks, often paired with Ipamorelin. Half-life: ~30 minutes (no DAC), ~8 days (with DAC). Use our peptide calculator for exact reconstitution math.

What are the side effects of CJC-1295?

Possible water retention, tingling/numbness in hands (carpal tunnel-like), increased appetite, mild headache, and flushing at injection site. Effects are dose-dependent and typically subside with continued use.

Is CJC-1295 safe?

CJC-1295 has shown a preliminary safety profile in research. Not FDA-approved. Research chemical status. Banned by WADA. All research should follow appropriate safety protocols.